Doctor profile · Federal record
Dr. Karen Harkaway, MD
Dermatology Physician (CMS: Dermatology) · Delran, NJ
- NPI 1093817280
- Accepts Medicare
- MIPS 79.6 / 100 · 2023
- 37 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
8001 Route 130 South
Delran, NJ 080751870
(856) 461-1400
fax (856) 461-2366
Credentials & registration
- NPI registered
- September 2006 — 20 yrs on file
- Profile last updated
- April 17, 2008
- Year of graduation
- 1989 — 37 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New Jersey #25MA05903200
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1093817280. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,591
Distinct HCPCS
10
Medicare allowed
$104,412
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 468 | 108 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 416 | 352 | $96 | |
17000 |
Destruction of precancer skin growth, 1 growth | 202 | 169 | $63 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 105 | 93 | $61 | |
17110 |
Destruction of skin growth, 1-14 growths | 96 | 88 | $122 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 90 | 90 | $118 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 56 | 25 | $1 | |
11102 |
Biopsy of related skin growth, first growth | 35 | 32 | $92 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 28 | 28 | $75 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 27 | 22 | $136 |
In context: peer comparison
Among 1 peers in Delran Dermatology Physician, average services per provider: 113. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$903
Transactions
55
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 12 | $175.68 | |
| Novartis Pharmaceuticals Corporation | 13 | $174.30 | |
| Incyte Corporation | 6 | $116.97 | |
| Pfizer INC. | 5 | $90.22 | |
| Lilly USA, LLC | 4 | $78.31 | |
| Genzyme Corporation | 3 | $56.01 | |
| Regeneron Healthcare Solutions, INC. | 3 | $52.85 | |
| Ucb, INC. | 2 | $32.66 | |
| Kerecis Limited | 1 | $28.21 | |
| Janssen Biotech, INC. | 1 | $21.25 | |
| Amgen INC. | 1 | $16.95 | |
| Sun Pharmaceutical Industries INC. | 1 | $16.10 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $15.75 | |
| Galderma Laboratories, L.P. | 1 | $13.83 | |
| Organon LLC | 1 | $13.78 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
405
Patients
165
Total drug cost
$58,446
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 124 | 82 | $1,257 |
| Ketoconazole | Generic | 68 | 31 | $1,501 |
| Minoxidil | Generic | 49 | 15 | $365 |
| Clobetasol Propionate | Generic | 48 | 25 | $4,440 |
| Fluocinolone Acetonide (Fluocinolone/Shower CAP) | Brand | 28 | 0 | $1,837 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 16 | 0 | $378 |
| Hydroxyzine Hcl | Generic | 14 | 0 | $143 |
| Ammonium Lactate | Generic | 12 | 0 | $208 |
| Dupixent Syringe (Dupilumab) | Brand | 12 | 0 | $45,619 |
| Mupirocin | Generic | 12 | 12 | $91 |
Frequently asked questions
What is Dr. Karen Harkaway's medical specialty?
Dr. Karen Harkaway practices Dermatology Physician in Delran, NJ.
Where does Dr. Karen Harkaway practice?
Dr. Karen Harkaway practices at 8001 Route 130 South, Delran, NJ 080751870. Office phone: 8564611400.
What is Dr. Karen Harkaway's NPI?
Dr. Karen Harkaway's National Provider Identifier (NPI) is 1093817280, issued by NPPES.
Does Dr. Karen Harkaway accept Medicare assignment?
Yes. Dr. Karen Harkaway accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Karen Harkaway commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.